| 1. |
Ikeguchi M, Oka A, Tsujitani S, et al. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer 〔Ｊ〕. Anticancer Research, 1994; 14(5B)∶2131.
|
| 2. |
朱少俊， 陳公高. 胃腸道惡性腫瘤術后早期腹腔內灌洗化療的臨床研究 〔Ｊ〕. 浙江醫學， 1995； 17(2)∶73.
|
| 3. |
Brenner ED. Intraperitoneal chemotherapy: a review 〔Ｊ〕. J Clin Oncol, 1986; 4(7)∶1135.
|
| 4. |
Sugarbaker HP. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis 〔Ｊ〕. Dis Colon Rectum, 1994; 37(2)∶S115.
|
| 5. |
卿三華， 周正端， 周錫庚等. 高劑量大容積5Fu腹腔化療藥代動力學和療效實驗觀察 〔Ｊ〕. 中國腫瘤臨床， 1996； 23(1)∶2.
|
| 6. |
陳軍， 尹浩然， 林言箴等. 胃癌術后早期表阿霉素腹腔內化療的藥代動力學變化 〔Ｊ〕. 腫瘤， 1997； 17(2)∶67.
|
| 7. |
Kuzuya T, Yamauchi M, Ito A. Pharmacokinetic characteristics of 5fluorouracil and mitomycin C in intraperitoneal chemotherapy 〔Ｊ〕. J Pharm Pharmacol, 1994; 46(8)∶685.
|
| 8. |
陳軍， 林言箴， 尹浩然等. 早期和延期腹腔內化療對結腸癌細胞腹腔種植的影響 〔Ｊ〕. 中國腫瘤臨床， 1997； 24(3)∶210.
|
| 9. |
Cohen CJ. Surgical considerations in ovarian cancer 〔Ｊ〕. Semin Oncol, 1985; 12(Suppl 4)∶53.
|
| 10. |
焦建峰， 王金銳. B超引導腹腔穿刺灌注化療 〔Ｊ〕. 中華超聲影像學雜志， 1993； 2(2)∶68.
|
| 11. |
Malmstrom H, Cartensen J, Simonsen E. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer 〔Ｊ〕. Gynecol Oncol, 1994; 54(1)∶27.
|
| 12. |
Weiber S, Graf W, Glimelius B, et al. Experimental colonic healing in relation to timing of 5Fu therapy 〔Ｊ〕. Br J Surgery, 1994; 81(11)∶1677.
|
| 13. |
Archer GS, Gray NB. Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastasis 〔Ｊ〕. Am J Surg, 1990; 159(3)∶325.
|
| 14. |
Kimura T, Akazai Y, Iwagaki H, et al. Metachronous liver metastasis of colorectal cancer: timing of occurrence and efficacy of adjuvant portal chemotherapy 〔Ｊ〕. Anticancer Research, 1995; 15(4)∶1585.
|
| 15. |
Ackermann N. Experimental studies on the role of the portal circulation in hepatic tumor vascularity 〔Ｊ〕. Cancer, 1986; 58(8)∶1653.
|
| 16. |
Speyer JL, Sugarbaker PH, Collins JM, et al. Portal levels and hepatic clearance of 5Fu after intraperitoneal administration in humans 〔Ｊ〕. Cancer Res, 1981; 41(5)∶1916.
|
| 17. |
馮國光， 周錫庚， 郁寶銘. 大腸癌根治術后肝轉移預防的實驗研究 〔Ｊ〕. 上海第二醫科大學學報， 1996； 16(4)∶237.
|
| 18. |
張新華， 梁石誠， 魏新林. 101例大腸癌術后肝轉移治療分析 〔Ｊ〕. 中華放射腫瘤學雜志， 1996； 5(4)∶240.
|
| 19. |
Taylor I, Rowling JT, West C. Adjuvant cytotoxic liver perfusion for colorectal cancer 〔Ｊ〕. Br J Surg, 1979; 66(12)∶833.
|
| 20. |
Schilsky R, Choi K, Grayhack J, et al. Phase I clinical and pharmacologic study of intraperitoneal cisplatin and 5Fu in patients with advanced intraabdominal cancer 〔Ｊ〕. J Clin Oncol, 1990; 8(12)∶2054.
|
| 21. |
Scheithauer W, Kornek G, Sebesta C, et al. Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma 〔Ｊ〕. Eur J Cancer, 1995; 31A(12)∶1981.
|
| 22. |
Lindner P, Carlson G, Gustavson B, et al. Biochemical modulation of intraperitoneal fluorouracil by allopurinolThe effect on an experimental adenocarcinoma in the liver 〔Ｊ〕. Anticancer Research, 1994; 14(3A)∶847.
|
| 23. |
Van Triest B, Van Groeningen C, Pinedo H. Current chemotherapeutic possibilities in the treatment of colorectal cancer 〔Ｊ〕. Eur J Cancer, 1995; 31A(7/8)∶1193.
|
| 24. |
Kimura M, Kinno T, Oda T, et al. Intracavitary treatment of malignant ascitic carcinomatosis with oily anticancer agents in rats 〔Ｊ〕. Anticancer Research, 1993; 13(5A)∶1287.
|
| 25. |
Yamada T, Sakatoku M, Ohhira M, et al. A new anticancer drug delivery system for the management of carcinomatous peritonitis 〔Ｊ〕. Surgery, 1991; 109(6)∶706.
|
| 26. |
Balthazar J, Fung H. Utilization of antidrug antibody fragment for the optimization of intraperitoneal drug therapy: studies using digoxin as a model drug 〔Ｊ〕. J Pharm Exp Therapeutics, 1994; 286(2)∶734.
|
| 27. |
Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for the prevention of peritoneal recurrence of gastric cancer 〔Ｊ〕. Cancer, 1994; 73(8)∶2048.
|
